In Australia, is Addyi (Flibanserin) available or what is available?
Australia Leads the Way in Androgen Treatment for Women with HSDD
While the US-approved drug flibanserin offers limited benefit for Hypoactive Sexual Desire Disorder (HSDD), it’s not approved in Australia—and comes with notable side effects.
Instead, Australia is the only country in the world to approve a regulated androgen hormone treatment specifically for postmenopausal women with HSDD. This topical therapy restores androgen levels to those typical of premenopausal women and is backed by decades of Australian-led research.
This marks a major step forward in addressing gender equity in sexual health care.
Latest News
How to talk to your Doctor about Sexual Health
What is HSDD? Hypoactive Sexual Desire Disorder Hypoactive Sexual Desire Disorder (HSDD) is a recognised and common medical condition characterised by persistently low sexual… Continue Reading →
Bringing sex back into the relationship in midlife couples
Midlife Sexuality: What You Need to Know Sexual health is a key part of quality of life, yet midlife brings changes that can impact… Continue Reading →
Improving Your Sexual Wellbeing: Practical Steps That Make a Difference
Sexual satisfaction isn’t about frequency—it’s about connection, comfort, and wellbeing. Sexual health is an important part of your overall wellbeing—and there are many ways… Continue Reading →